Integer Holdings Co. (NYSE:ITGR) Given Average Recommendation of “Moderate Buy” by Analysts

Shares of Integer Holdings Co. (NYSE:ITGR) have received an average rating of “Moderate Buy” from the seven ratings firms that are covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a hold rating and six have given a buy rating to the company. The average twelve-month price objective among brokerages that have issued ratings on the stock in the last year is $133.86.

ITGR has been the topic of a number of research reports. KeyCorp raised their price objective on shares of Integer from $123.00 to $139.00 and gave the stock an “overweight” rating in a report on Tuesday, April 9th. Benchmark reissued a “buy” rating and set a $130.00 price objective on shares of Integer in a research report on Friday. Truist Financial started coverage on Integer in a report on Wednesday, May 15th. They issued a “buy” rating and a $137.00 target price on the stock. Bank of America raised Integer from a “neutral” rating to a “buy” rating and boosted their price target for the company from $105.00 to $135.00 in a report on Monday, April 15th. Finally, Oppenheimer assumed coverage on Integer in a research note on Tuesday, July 16th. They issued an “outperform” rating and a $135.00 price objective on the stock.

Integer Trading Down 3.8 %

Shares of ITGR stock opened at $111.77 on Tuesday. The stock has a market capitalization of $3.75 billion, a P/E ratio of 38.67, a P/E/G ratio of 1.70 and a beta of 1.11. The company has a current ratio of 3.29, a quick ratio of 1.96 and a debt-to-equity ratio of 0.73. The firm’s 50 day moving average is $118.63 and its 200 day moving average is $113.80. Integer has a 12-month low of $69.40 and a 12-month high of $130.15.

Integer (NYSE:ITGR) last issued its quarterly earnings data on Thursday, July 25th. The medical equipment provider reported $1.30 EPS for the quarter, topping the consensus estimate of $1.24 by $0.06. Integer had a return on equity of 11.48% and a net margin of 6.31%. The company had revenue of $436.20 million during the quarter, compared to analyst estimates of $437.00 million. During the same quarter in the previous year, the company posted $1.14 earnings per share. Integer’s revenue was up 9.0% compared to the same quarter last year. Research analysts expect that Integer will post 5.31 earnings per share for the current year.

Insider Buying and Selling

In other news, Director Jean M. Hobby sold 11,960 shares of Integer stock in a transaction that occurred on Wednesday, July 31st. The shares were sold at an average price of $119.66, for a total transaction of $1,431,133.60. Following the sale, the director now owns 2,280 shares in the company, valued at $272,824.80. The transaction was disclosed in a document filed with the SEC, which is available at this link. In other Integer news, Director Jean M. Hobby sold 11,960 shares of the stock in a transaction dated Wednesday, July 31st. The shares were sold at an average price of $119.66, for a total transaction of $1,431,133.60. Following the completion of the transaction, the director now owns 2,280 shares of the company’s stock, valued at approximately $272,824.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider John A. Harris 3,400 shares of the stock in a transaction on Tuesday, July 30th. The disclosure for this trade can be found here. In the last three months, insiders have sold 28,396 shares of company stock valued at $3,391,070. Corporate insiders own 2.00% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of ITGR. Handelsbanken Fonder AB lifted its stake in shares of Integer by 1.7% in the 4th quarter. Handelsbanken Fonder AB now owns 5,837 shares of the medical equipment provider’s stock valued at $578,000 after purchasing an additional 100 shares during the last quarter. Cornercap Investment Counsel Inc. lifted its position in Integer by 1.0% in the fourth quarter. Cornercap Investment Counsel Inc. now owns 12,014 shares of the medical equipment provider’s stock worth $1,190,000 after buying an additional 121 shares during the last quarter. Quadrant Capital Group LLC boosted its stake in Integer by 10.2% during the fourth quarter. Quadrant Capital Group LLC now owns 1,427 shares of the medical equipment provider’s stock worth $141,000 after buying an additional 132 shares during the period. GAMMA Investing LLC increased its position in Integer by 60.9% during the second quarter. GAMMA Investing LLC now owns 375 shares of the medical equipment provider’s stock valued at $43,000 after acquiring an additional 142 shares during the last quarter. Finally, KLR Investment Advisors LLC raised its stake in shares of Integer by 4.9% in the fourth quarter. KLR Investment Advisors LLC now owns 3,996 shares of the medical equipment provider’s stock valued at $396,000 after acquiring an additional 185 shares during the period. 99.29% of the stock is currently owned by institutional investors.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.